MDxHealth (MDXH) Short term Debt (2020 - 2026)

MDxHealth has reported Short term Debt for 7 years, with the latest figure at $95.9 million in Q1 2026.

• Quarterly Short term Debt rose 27.31% year-over-year to $95.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $95.9 million (up 27.31% YoY) and the FY2025 annual result came in at $76.2 million, up 23417.59% from the prior year.
• Short term Debt advanced to $95.9 million in Q1 2026 per MDXH's latest filing, from $76.2 million in the prior quarter.
• Over five years, Short term Debt peaked at $75.7 billion in Q2 2025 and troughed at $324000.0 in Q4 2024.
• A 5-year average of $5.1 billion and a median of $35.8 million in 2024 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2023 and 2025: Short term Debt tumbled 98.16% in 2023, then soared 147341.14% in 2025.
• Over 5 years, Short term Debt stood at $34.9 million in 2022, then sank by 98.16% to $643000.0 in 2023, then tumbled by 49.61% to $324000.0 in 2024, then soared by 23417.59% to $76.2 million in 2025, then gained by 25.92% to $95.9 million in 2026.
• According to Business Quant data, Short term Debt over the past three periods registered $95.9 million, $76.2 million, and $75.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.